MXPA97003737A - Oxidasas containing copper useful as oxidasasde yod - Google Patents
Oxidasas containing copper useful as oxidasasde yodInfo
- Publication number
- MXPA97003737A MXPA97003737A MXPA/A/1997/003737A MX9703737A MXPA97003737A MX PA97003737 A MXPA97003737 A MX PA97003737A MX 9703737 A MX9703737 A MX 9703737A MX PA97003737 A MXPA97003737 A MX PA97003737A
- Authority
- MX
- Mexico
- Prior art keywords
- laccase
- enzyme
- oxidation
- abts
- oxidase
- Prior art date
Links
- 239000010949 copper Substances 0.000 title claims abstract description 21
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 229910052802 copper Inorganic materials 0.000 title claims abstract description 17
- 108010029541 Laccase Proteins 0.000 claims abstract description 64
- 230000003647 oxidation Effects 0.000 claims abstract description 51
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 51
- 102000004190 Enzymes Human genes 0.000 claims abstract description 46
- 108090000790 Enzymes Proteins 0.000 claims abstract description 46
- 108020005203 Oxidases Proteins 0.000 claims abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims abstract description 17
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000011630 iodine Substances 0.000 claims abstract description 13
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 13
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N ABTS Chemical group S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 claims description 46
- 108010015428 bilirubin oxidase Proteins 0.000 claims description 23
- 241000226677 Myceliophthora Species 0.000 claims description 6
- 230000002538 fungal Effects 0.000 claims description 6
- 241000222640 Polyporus Species 0.000 claims description 4
- 241001361634 Rhizoctonia Species 0.000 claims description 3
- 241000223255 Scytalidium Species 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 2
- 241001465180 Botrytis Species 0.000 claims description 2
- 241000222680 Collybia Species 0.000 claims description 2
- 241000222511 Coprinus Species 0.000 claims description 2
- 241000222356 Coriolus Species 0.000 claims description 2
- 241000123326 Fomes Species 0.000 claims description 2
- 241000222418 Lentinus Species 0.000 claims description 2
- 241000221960 Neurospora Species 0.000 claims description 2
- 241000222395 Phlebia Species 0.000 claims description 2
- 241000222350 Pleurotus Species 0.000 claims description 2
- 241000221945 Podospora Species 0.000 claims description 2
- 241000222354 Trametes Species 0.000 claims description 2
- 241000223251 Myrothecium Species 0.000 claims 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 22
- 239000000758 substrate Substances 0.000 description 17
- 229940088598 Enzyme Drugs 0.000 description 16
- 108060008724 EC 1.14.18.1 Proteins 0.000 description 10
- 102000003425 EC 1.14.18.1 Human genes 0.000 description 10
- 108010075016 Ceruloplasmin Proteins 0.000 description 9
- 238000006555 catalytic reaction Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 102100006077 CP Human genes 0.000 description 8
- 230000035969 Vmax Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 7
- 230000000249 desinfective Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000002255 enzymatic Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- MYNVJNZGTAVRJD-UHFFFAOYSA-N 4-[[2-[(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]hydrazinyl]methylidene]-2,6-dimethoxycyclohexa-2,5-dien-1-one Chemical compound C1=C(OC)C(=O)C(OC)=CC1=CNNC=C1C=C(OC)C(=O)C(OC)=C1 MYNVJNZGTAVRJD-UHFFFAOYSA-N 0.000 description 3
- VWDWKYIASSYTQR-UHFFFAOYSA-N Sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 239000000383 hazardous chemical Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory Effects 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 241001103808 Albifimbria verrucaria Species 0.000 description 2
- 230000036715 Apparent Km Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 229940072417 Peroxidase Drugs 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 108090000437 Peroxidases Proteins 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M Potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 241001313536 Thermothelomyces thermophila Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- -1 alkali metal salts Chemical class 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000003334 potential Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910001428 transition metal ion Inorganic materials 0.000 description 2
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N 2,2'-bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2H-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000031088 EC 1.10.3.1 Human genes 0.000 description 1
- 108010031396 EC 1.10.3.1 Proteins 0.000 description 1
- 108091003147 Electron Transport Complex IV Proteins 0.000 description 1
- 102000011686 Electron Transport Complex IV Human genes 0.000 description 1
- 241000127897 Ganoderma tsunodae Species 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 229940035535 Iodophors Drugs 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 210000002381 Plasma Anatomy 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000996 additive Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229910002056 binary alloy Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N chlorine Chemical class ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 108010010085 ferroxidase II Proteins 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 108010090622 glycerol oxidase Proteins 0.000 description 1
- 101700082094 griF Proteins 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M methanoate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative Effects 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 101700001698 phsA Proteins 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- 229910052904 quartz Inorganic materials 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000004642 transportation engineering Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
A method for the oxidation of iodide is described, which comprises contacting, in an aqueous solution, an oxidase enzyme containing copper and a source of ionic iodide (I ') for a time and under conditions sufficient to allow conversion of iodine iodide to iodine by the enzyme. Enzymes containing copper can be, for example, a laccase oxidase or bilirubin
Description
OXIDASE CONTAINING USEFUL COPPER AS YODIDE OXIDASE Field of the invention The present invention relates to a method for the oxidation of iodide. More specifically, the invention relates to the use of copper containing oxidases, particularly laccases, in the oxidation of iodide.
BACKGROUND OF THE INVENTION Iodine (12) has been widely used for many years as a disinfectant for many types of situations. Skin cleansers, wound disinfection, contact lens cleaning and water hygiene are only a few of the uses to which iodine has been applied. In addition, iodine is useful in catalysts, an additive for animal feed, in pharmaceuticals and as precursor additives for polymers. Although the system of disinfection based on is extremely effective, several factors limit the scope of directly applying the. In particular, production, storage, transportation and handling are extremely dangerous, due to the chemical compounds involved and also due to the toxicity of the same I2 even at moderate concentrations. In general, I2 is obtained from natural sources, such as brine, through processes that use strong inorganic acids, chlorine gas and other hazardous chemical compounds REF: 24793. Iodophors have been developed as carriers of I2 to replace simple l2 solutions for industrial and domestic disinfection. In addition, binary systems capable of generating l2 from a salt of I "and a chemical oxidant are also available, both of which create the need to dispose of potentially toxic large amounts of byproducts. scale and apply I2 as a disinfectant has been found in the generation of l2 based on peroxidase (US patents Nos. 4,282,324, 4,617,190, 4,588,586, 4,937,072, 5,055,287, 5,227,161, 5,169,455, 4,996,146, 4,576,817). of enzymatic peroxidase, the oxidizing agent H2O2 and a source of iodide icr-iao Unfortunately, this method has the disadvantage of requiring hazardous and volatile peroxide or perishing, which has to be either transported or generated in situ by enzymatic steps or additional chemicals, to make the system more complex and expensive .There is thus a need for a method for the production of iodine ion which avoids the need to deal with hazardous chemical compounds either in the plant or in situ and still efficiently produce sufficient quantities of the desired product. The present invention now provides a means to obtain this.
SUMMARY OF THE INVENTION The present invention relates to a method for the production of iodine. The method comprises contacting, in an aqueous solution, a copper-containing oxidase enzyme and a source of ionic iodide (I ") for a time and under conditions sufficient to allow the conversion of the ionic iodide to iodine by the enzyme. a preferred embodiment, the enzyme is either a laccase or bilirubin oxidase.In another preferred embodiment, the method is also carried out in the presence of a substrate with high affinity for the copper-containing enzyme.The substrate acts as a mediator, which it releases electrons in the reaction, thereby improving the rate at which the oxidation of I 'is carried out.When using laccase or oxidized bilirubin, the ABTS substrate is a particularly useful mediator in the oxidation process.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 illustrates double reciprocal plots for oxidation of the
I 'catalyzed by the laccase Myceliophthora thermophila recombinante (r-MtL). (A) Correlations between initial velocities and concentrations of I- at various pH with 14 μM r-MtL. (B) Dependencies of Km and Vmax (extracted from Figure 1A) on the pH. Figure 2 illustrates the oxidation of I 'catalyzed by rMtL, aided by ABTS. (A) The dependence of the oxidation rates of the initial I "on ABTS and r-MtL concentrations (nM). (B) The pH profile of the oxidation rate of the initial I" with r-MtL 2.4 nM and ABTS 10 μM.
DETAILED DESCRIPTION OF THE INVENTION It has been well documented that certain halide molecules are capable of inhibiting laccase. Specifically, the inhibition of tree and fungal laccases has been described by fluoride (F ") (Koudelka and Ettinger, J. Biol. Chem. 263: 2698-3705, 1988), as well as the inhibition of fungal laccases by bromide (Br ") and chloride (CI") (Naki and Varfolomeev, Biokhimya 46: 1694-1702, 1981). These halides are supposed to interact with the type II copper site of the laccase to result in the interruption of the Transfer of electrons from the site of type I to the dioxygen site The interaction of the laccase with the iodide (I ') has not been previously reported, since the halide inhibition potency is inversely related to the size of the ionic radius, it would be expected that the I ", with the larger ionic radius, would have a weak inhibitory effect on the laccase. However, it is quite surprising to find that I "acts in effect as a substrate by yielding an electron to type I copper. The observation that I" can act as a laccase substrate has led to the development of a method by which I 'is oxidized to elemental iodine by the use of a laccase or other oxidase enzymes containing copper. In an aqueous solution, in which a source of ionic iodide is provided, the laccase slowly converts the I "to I2.The conversion does not require volatile or hazardous chemical compounds such as chlorine.The source of ionic iodide can be any of the currently known sources, such as alkali metal salts in binary iodine disinfectants, raw brine solutions or initially separated from iodine, mother liquor (salines), ionic iodide solutions in which the caliche iodate (sodium nitrate) is reduced to iodine or algae In the case in which the chloride is inhibitory to the enzyme used, the residual chlorine in the starting material must first be reduced to less than the inhibition constant.In the case of Myceliophthora laccase, the constant of inhibition is about 70 nM The enzyme employed in the present process can be any of a variety of oxidase enzymes containing Cu. As the following examples show , although the laccase is the most active in the oxidation of I ', there are other similar enzymes which also provide a qualitatively similar activity, although in many cases at considerably lower levels than the laccase. In particular, the bilirubin oxidase exhibits an activity which is essentially equivalent to that of the laccase. However, other copper-containing enzymes tested, such as tyrosinase and ceruloplasmin, also show some level of activity, indicating that utility is not limited to laccase. Copper containing oxidases are obtainable from a wide variety of plant, fungal, bacterial and animal sources and many are commercially available. In addition to those enzymes listed above, these also include polyphenol oxidase, ferroxidase II, phenoxazinone synthase, glycerol oxidase, and cytochrome oxidase. The preferred oxidase, laccase, is available from a variety of species, particularly the fungal species, for example Aspergillus, Neurospora, Podospora, Botrytis, Collybia, Fomes, Lentinus, Pleurotus, Trametes, Rhizoctonia (US patent application Serial No. 08) / 172,331, incorporated herein by reference), Coprinus, Psatyrella, Myceliophthora (U.S. Patent Application Serial No. 08 / 253,781, incorporated herein by reference), Scytalidium (U.S. Patent Application Serial No. 08 / 253,784 , incorporated herein by reference), Polyporus (U.S. Patent Application Serial No. 08 / 265,534, incorporated herein by reference), Phlebia (WO 92/01046) and Coriolus (JP 2-238885). Additionally, bilirubin oxidase is readily available from Myrothecium verrucaria and Trachyderma tsunodae. The reaction is carried out in aqueous solution. The enzyme can be free or in pure or crude form or immobilized on an organic or inorganic support by any means known in the art., for example polyacrylamide, cellulose, glass beads, agarose, dextran, methacrylic polymers or ethylenemalic acid copolymers. Reactions with immobilized enzymes can be carried out in tanks or in columns. The reaction can also be carried out with microbial cells which produce the enzyme. The aqueous solution is regulated to a pH which provides an optimal activity for the enzyme that is used and thus the pH of the solution will vary depending on the enzyme used. The pH is maintained in the preferred range by the use of an appropriate pH regulating agent. Such pH regulators include buffer solutions of phosphate, gluconate, citrate, formate or sodium or potassium acetate. The amount of enzyme used will also vary depending on the identity of the enzyme used, but in general it will be in the range of nM to μM. The amount of I 'used in the reaction mixture should preferably be at mM or higher levels. The reaction can be conducted at a temperature between about 15-50 ° C, but is preferably carried out at a temperature of about 20-30 ° C. In a preferred embodiment of the present method, the reaction as described above is carried out in the presence of a mediator which accelerates the conversion rate of I 'to I2. Although copper-containing enzymes such as laccase oxidize I-, production is usually slow due to low affinity. Accordingly, a compound which has high affinity for the enzyme and which can act as an intermediate in releasing electrons between the enzyme and I ', can improve the efficiency of the reaction. For example, as shown in the examples below, the compound 2,2'-az-rα ± -Ls- (3-ethylbenzthiazoline-6-sulfonic acid) (ATBS), which is a known and excellent substrate for laccase and bilirubin oxidase, greatly improves the efficiency of oxidation of 17 Although ABTS may not be useful for improving the reaction rate with other copper-containing enzymes, such as tyrosinase and ceruloplasmin, since it is not an excellent substrate for these enzymes, alternative mediators can be used which are more appropriate substrates with these enzymes. The important factors in the selection of alternative mediators for any given enzyme is that the mediator is a good substrate for the enzyme and has a redox potential similar or higher than I. "Examples of additional mediators which should be useful for reactions using enzymes other than laccase and bilirubin oxidase are phenolic compounds, heterocyclic hydroquinones and free transition metal ions or coordinated chelates (ie, Fe2 *, Fe (bipyridyl) 22+, Ru (CN) 6 * ", and the like The amount of the mediator will differ depending on the identity of the compound used and its convenience based on the favorable characteristics affirmed; for ABTS, which is an ideal mediator for laccase and bilirubin oxidase when judged by the stated criteria, only a small amount, approximately 0.1 mM, is required to improve the reaction 103 times over the results observed in the absence of ABTS. For any given mediator, the concentration used depends on its Km for the enzyme that is used, which value can be determined systematically by the one skilled in the art. The iodine produced in the course of the reaction can be recovered by any appropriate means, such as filtration / centrifugation, blowing with inert gas and extraction by immiscible organic solvents. The invention is further illustrated by the following non-limiting examples.
EXAMPLES I Materials and Methods A. Materials The chemical compounds used as buffer solutions and substrates are commercial products of at least reactive grade. The ascorbate oxidase (Cucurbita species), ceruloplasmin (porcine plasma), bilirubin oxidase (Myrothecium verrucaria) and tyrosinase (mushrooms) are purchased from Sigma and used as received. The content of the lyophilized powder enzymes or solution is confirmed by UV-visible absorption and published extinction coefficients. The claimed activity of ascorbate oxidase is confirmed with ascorbic acid.
B. Methods The recombinantly produced Myceliophthora thermophila laccase (r-MtL, described in copending patent application Serial No. 08 / 278,473, the content of which is incorporated herein by reference) is purified and the activity is determined by oxidations with syringaldazine and 2,2'-azinobis- (3-ethylbenzthiazo! in-6-sulfonic acid) (ABTS) as follows: Oxidation of syringaldazine is carried out at 30 ° C in a quartz cuvette of 1 cm. 60 μl of concentrated syringaldazine solution (0.28 mM in 50% methanol) and 20 μl of sample are mixed with 0.8 ml of pre-warmed pH buffer. Oxidation is verified at 530 nm for 5 minutes. The ABTS oxidation analyzes are made by using 0.4 mM ABTS, pH regulating solution of B & R at various pH, at room temperature when verifying the absorption change at 418 nm. The extinction coefficient of 36 mM "1cm" 1 is used to calculate the velocity. Spectroscopic analyzes are carried out either on a spectrophotometer (Shimadzu UV160) or a microplate reader (Molecular Devices). PH buffer solutions of Britton & Robinson according to the standard protocol (Quelle, Biochemisches Taschenbuch, H.M. Raven, II, Teil, S.93, 102, 1964). The enzymatic assays for the determination of I 'are carried out in B & R buffer which contains 1-20 nM of MtL (concentration in subunits) and 10 to 200 mM of Nal at 20 ° C for 5 10 minutes. The extinction coefficient of 26 mM "1cm" 1 is used to calculate the velocity. The oxidation of I 'is verified spectrally at 340 or 353 nm and the spectra of the oxidation product is identical to that of l3"(Hosoya, Biochem. (Tokyo) 53: 381, 1963) .The kinetic parameters are extracted by a linear regression adjustment (Prism, GraphPad) of velocity and concentration data to the velocity equation = Vma? * [substrate] / Km + [substrate] .Ascorbate oxidase, ceruloplasmin, bilirubin oxidase and tyrosinase at concentrations up to μM level are also tested under similar conditions for oxidation catalysis of I '.
II Results Catalysts for oxidation of I "by rMtL and other enzymes containing copper In aerated solution, I" can be oxidized slowly to I2. When the I "(in the form of Nal) is in excess, the I3" is formed irreversibly from I "and l2 to give a characteristic spectrum with a band centered around 353 (Hosoya, supra). -MtL can accelerate the process, at a pH of about 3, the oxidation of catalyzed I can be many orders faster than non-enzymatic oxidation. The reciprocals of the initial velocities of the formation of l2 and the concentration of I "exhibit a classical linear correlation (Figure 1A) Over the proven range of 1.15 μM, the maximum initial velocities are proportional to the concentration of r-MtL. activity is optimal at pH 3.4 At a pH higher than 6, the reaction is minimal, as a substrate the I "shows an apparent Km dependent on the pH. The smallest Km, 0.16 ± 0.02 M, is at pH 3.4. The pH dependence of Vma is less significant (figure 1 B). At a pH of 3.4, a Vma of 2.7 ± 0.2 cycles per minute is found. I "is not as good substrate for r-MtL as syringaidazine, whose Km and Vmax at optimum pH (7) are approximately 10 μM and production levels of approximately 400 cycles per minute respectively., ascorbate oxidase at concentrations up to 1.5 μM shows an activity of less than 0.1 cycles per minute. At the μM level, ceruloplasmin shows negligible catalysis in the oxidation of I 'with 0.1 M Nal at pH 6 (approximately 0.1 cycles per minute). As an oxidase of I ", tyrosinase has a pH-activity profile in which the relative activity at pH 4.1, 5.2, 6.0 and >; 7 is -58, 33, 10 and < 5% of that at pH 2.7 respectively. At its optimum pH of 2.7, tyrosinase catalyses the oxidation of I "with a Km of -0.1 M and a Vmax of -0.1 cycles per minute.The initial oxidation rates of I" are proportional to the concentration of tyrosinase over a range from 2 to 20 μM. As an oxidase of I ', the bilirubin oxidase has a pH activity profile in which the relative activity at pH 2.7, 5.2, 6.0, 7.0, 8.2 and > 9 is -95, 91, 80, 59, 32 and < 6% of that at pH 4.1 respectively. At its optimum pH of 4.1, the bilirubin oxidase catalyses the I "with a Km of -0.15 ± 0.03 M and a Vmax of 1.7 ± 0.1 cycles per minute.The initial velocities are proportional to the concentration of bilirubin oxidase over the range of 0.5-5 μM.
Catalysis for oxidation by ABTS. At pH 5, the ascorbate oxidase at concentrations up to 1.5 μM shows no activity in the ABTS oxidation. The oxidation rates of ABTS catalyzed by tyrosinase are proportional to the concentration of tyrosine over the 0.2-2 μM range tested. Tyrosinase has an optimal activity at pH 2.7, of which one Km is 0.18 ± 0.0 1 mM and a Vmax of 3.1 ± 0.1 cycles per minute. The initial rates of oxidation of ABTS catalyzed by ceruloplasmin are proportional to a concentration of ceruloplasmin over the range of 0.1 to 1 μM tested. Ceruloplasmin has an optimal ABTS oxidase activity at pH 4.1 of which is one Km of 0.11 ± 0.04 mM and a Vmax of 9.3 ± 1.3 cycles per minute. The initial oxidation rates of the ABTS catalyzed by the bilirnjbin oxidase are proportional to the oxidase concentration over the 1-10 nM range tested. The pH profile shows an optimum pH of 4.1, of which one Km is 0.12 ± 0.01 mM and one Vma? of (1310 ± 40) cycles per minute. RMtL has an activity pH profile with an optimum pH < 2.7. At pH 4.1, the ABTS has a Km of 5.6 ± 0.5 μM and a Vmax of 1460 ± 31 cycles per minute is found.
Catalysis aided by ABTS. The oxidized ABTS (ABTS +), prepared by pre-incubation with laccase, easily oxidizes I. "In the presence of small amounts of ABTS, the oxidation of I" catalyzed by laccase can be greatly improved (Figure 2A). Kinetic analysis shows that the step that limits speed lies in the oxidation of ABTS through laccase. When the ABTS and I 'are present at sufficient levels, only the spectrum of l3 ~ is detected while the I "remains in excess with respect to the ABTS.At the time the I" is consumed, the spectrum of the oxidized ABTS arises. In the enzymatic catalysis assisted by ABTS of the oxidation of I ", the pH-activity profile (Figure 2B) is similar to that for the oxidation of ABTS catalyzed by rMtL (optimum pH displaced from 3.4 to <2.7). apparent and the Vma (6.4 ± 0.8 μM and 860 ± 40 cycles per minute) extracted from the dependence of oxidation velocities of I- on the concentration of ABTS are close to those of oxidation catalyzed by r-MtL of ABTS itself. Due to its poor activities of ABTS oxidase, ascorbate oxidase, ceruloplasmin and tyrosinase all show a negligible ABTS-assisted catalysis for oxidation of I ". When ABTS is included in the oxidation of I 'catalyzed by bilirubin oxidase, an optimal activity at pH 4.1 is observed. At this pH, an apparent Km of 0.18 ± 0.02 mM and a Vma? of 600 ± 40 cycles per minute for the oxidation of I. "These kinetic parameters, which are close to those for the oxidation of ABTS catalyzed by oxidase itself, indicate that the stage that limits the speed in the catalysis is the oxidation of the ABTS .
Discussion. There have been no previous reports describing the oxidase activity of I 'of the laccase or oxidation of I' catalyzed by oxidase. Although it is known that F "and probably also IC" and Br "are linked to Cu type II in the laccase, the observed catalysis of the laccase in the oxidation of I" implies that I "must interact with copper, I. The redox potentials (against the Normal Hydrogen Electrode (NHE)) of Cu type I are in the range of 480 to 530 mV against the NKE for the r-MtL and the bilirubin oxidase, and approximately 8Q0 mV for the Lacasa Polyporus (Reinhammar, Biochim, Biophys, Acta 275: 245-259, 1972) The potential for the ABTS + / ABTS pair is approximately 7QQ-raV .. These potentials are close to or greater than the l37l pair "(540). mV) to do so to the oxidation of I "by Cu type I or ABTS * thermodynamically feasible.Although I" could be a potentially stronger reducer than ABTS, kinetic factors make the former much less reactive towards the laccase. As a substrate, the ABTS has a Km -103 times smaller and a Vmax -103 times larger compared to the I. "Because the oxidized ABTS freely exchanges electrons with the I" in solution, the electron exchange by the ABTS and the Lacasa greatly improves the oxidation of I "catalyzed by laccase Since the step that limits the speed is the oxidation of ABTS, it is possible to regulate the catalysis for the oxidation of I" by the concentration of ABTS or other appropriate mediators. Among the copper-containing enzymes tested, bilirubin oxidase functions quantitatively similar to laccase, while the other enzymes tested function to direct oxidation of I 'less efficiently. Since ABTS itself is not an excellent substrate for ascorbate oxidase, ceruplasmia and tyrosine, only a minor effect of ABTS to aid oxidation of I 'catalyzed by these enzymes would be expected. However, other materials which are good substrates for these enzymes, such as phenolic compounds, hydroquinones, heterocyclics and chelate or free transition metal ions can be used as alternative mediators with these enzymes for I oxidation.
It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention is that which is clear from the present description of the invention.
Having described the invention as above, property is claimed as contained in the following
Claims (18)
- Claims 1. A method for the oxidation of iodide, characterized in that it comprises contacting, in an aqueous solution, an oxidase enzyme containing copper and a source of ionic iodide (D. for a time and under conditions sufficient to allow conversion of iodine iodide to iodine by the enzyme.
- 2. The method according to claim 1, characterized in that the enzyme is laccase or bilirubin oxidase.
- 3. The method according to claim 2, characterized in that the laccase is a fungal laccase or bilirubin oxidase.
- 4. The method according to claim 3, characterized in that the enzyme is a laccase.
- 5. The method according to claim 3, characterized in that the enzyme is a laccase selected from the group consisting of Myceliophthora laccase, a Scytalidium laccase, a Polyporus laccase and a Rhizoctonia laccase, an Aspergillus laccase, a Neurospora laccase, a Podospora laccase, an laccase Botrytis, a laccase Collybia, laccase Fomes, laccase Lentinus, laccase Pleurotus, laccase Trametes, laccase Coprinus, laccase Psatryella, laccase Phlebia and laccase Coriolus.
- 6. The method according to claim 1, characterized in that the enzyme is a Myceliophthora laccase, a Scytalidium laccase, a Polyporus laccase or a Rhizoctonia laccase.
- 7. The method according to claim 1, characterized in that the enzyme is a Myceliophthora laccase.
- 8. The method according to claim 3, characterized in that the enzyme is a bilirubin oxidase.
- 9. The method according to claim 3, characterized in that the enzyme is a bilirubin oxidase Myrothecium or Trachyderma.
- 10. The method according to claim 3, characterized in that the enzyme is Myrothecium bilirubin oxidase.
- 11. The method according to claim 1, characterized in that it is carried out in the presence of a mediator.
- 12. The method according to claim 1, characterized in that the mediator is ABTS.
- 13. A method for the oxidation of iodide, characterized in that it comprises contacting, in an aqueous solution, a fungal laccase or a bilirubin oxidase and a source of ionic iodide (I ") in the presence of a mediator, for a time and under conditions sufficient to allow the conversion of ionic iodide to iodine by the enzyme.
- 14. The method according to claim 13, characterized in that the mediator is ABTS.
- 15. The method according to claim 14, characterized in that the enzyme is a laccase.
- 16. The method according to claim 15, characterized in that the enzyme is a Myceliophthora laccase.
- 17. The method according to claim 14, characterized in that the enzyme is a bilirubin oxidase.
- 18. The method according to claim 17, characterized in that the bilirubin oxidase is a bilirubin oxidase Myrothecium.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/343,308 US5766896A (en) | 1994-11-22 | 1994-11-22 | Method of producing iodine by use of a copper containing oxidase enzyme |
US08343308 | 1994-11-22 | ||
PCT/US1995/015377 WO1996016165A1 (en) | 1994-11-22 | 1995-11-20 | Copper containing oxidases useful as iodide oxidases |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9703737A MX9703737A (en) | 1997-09-30 |
MXPA97003737A true MXPA97003737A (en) | 1998-07-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Van Deurzen et al. | Chloroperoxidase: use of a hydrogen peroxide-stat for controlling reactions and improving enzyme performance | |
Morozova et al. | Laccase-mediator systems and their applications: a review | |
Margot et al. | Sulfamethoxazole and isoproturon degradation and detoxification by a laccase-mediator system: influence of treatment conditions and mechanistic aspects | |
Pita et al. | Direct heterogeneous electron transfer reactions of fungal laccases at bare and thiol-modified gold electrodes | |
Van Schijndel et al. | The stability and steady‐state kinetics of vanadium chloroperoxidase from the fungus Curvularia inaequalis | |
Hollenberg et al. | The reaction of chlorite with horseradish peroxidase and chloroperoxidase: enzymatic chlorination and spectral intermediates | |
Butler et al. | Vanadium bromoperoxidase and functional mimics | |
Xu | Catalysis of novel enzymatic iodide oxidation by fungal laccase | |
KASAHARA et al. | Succinate-and NADH Oxidase Systems of Escherichia coli Membrane Vesicles Mechanism of Selective Inhibition of the Systems by Zinc Ions | |
Xu | Dioxygen reactivity of laccase: dependence on laccase source, pH, and anion inhibition | |
Tinoco et al. | Role of oxidizing mediators and tryptophan 172 in the decoloration of industrial dyes by the versatile peroxidase from Bjerkandera adusta | |
WO1995027009A1 (en) | Antifouling paint containing haloperoxidases and method to determine halide concentrations | |
Nicholls et al. | Oxidation of sulphide by cytochrome aa3 | |
Adewuyi et al. | Kinetics of oxidation of dimethyl sulfide by hydrogen peroxide in acidic and alkaline medium | |
US5766896A (en) | Method of producing iodine by use of a copper containing oxidase enzyme | |
Rau et al. | Vanadate-stimulated NADH oxidation in microsomes | |
MXPA97003737A (en) | Oxidasas containing copper useful as oxidasasde yod | |
Reipa et al. | Redox control of the P450cam catalytic cycle: effects of Y96F active site mutation and binding of a non-natural substrate | |
Shoun et al. | Inhibition of p-hydroxybenzoate hydroxylase by anions: possible existence of two anion-binding sites in the site for reduced nicotinamide adenine dinucleotide phosphate | |
Fujiwara et al. | aa 3-type cytochrome c oxidase occurs in Halobacterium halobium and its activity is inhibited by higher concentrations of salts | |
Tinoco et al. | Biochemical method for chlorine dioxide determination | |
Pasta et al. | Effects of chloride on the kinetics and stereochemistry of chloroperoxidase catalyzed oxidation of sulfides | |
Arnao et al. | Role of the reductant substrates on the inactivation of horseradish peroxidase by m‐Chloroperoxybenzoic acid | |
Khammuang et al. | Mediator-assisted rhodamine B decolorization by Tramates versicolor laccase | |
Schwimmer | L-Cysteine sulfoxide lyase competition between enzyme and substrate for added pyridoxal phosphate |